Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients in Real Life Condition in Czech Republic (UFO).

Trial Profile

Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients in Real Life Condition in Czech Republic (UFO).

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2011

At a glance

  • Drugs Beclometasone/formoterol; Budesonide/formoterol; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms UFO
  • Sponsors AstraZeneca
  • Most Recent Events

    • 22 Jul 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top